In a Truth Social post, Trump noted that the White House would place a 100% tariff on “any branded or patented” pharmaceutical product — unless a company was investing in manufacturing facilities in ...

After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent ...

International companies with heavy Massachusetts footprints are largely protected by that caveat. Drug makers from Moderna to ...

The FDA re-approved Wellcovorin, a drug from GSK, that the company stopped selling more than 25 years ago, as part of a push from the Trump administration to identify the causes of and potential ...

US President Donald Trump has dropped a bombshell on the pharmaceutical world, announcing a 100 per-cent tariff on all imported branded and patented drugs, effective 1 October. Generic medicines, the ...

Trump drug tariffs announced 100% duties on branded drugs by October 1st, impacting global pharmaceutical manufacturers, ...

On 6 August 2025, Sampo announced a share buyback programme of up to a maximum of EUR 200 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated ...

Kendall Square, a major biopharmaceutical hub that borders the Massachusetts Institute of Technology’s campus, bills itself ...

Ionis Pharmaceuticals IONS announced positive topline results from a pivotal phase III study evaluating its investigational ...

Hello PLC Alumni! The Buffs are back for a new school year, which means we're back for a new alumni newsletter! My name is Maneesh Gundluru, and I am the new alumni connections coordinator! I'm now ...